Clinical Trials of Adenoid Cystic Carcinoma Cancer effectively evaluate and justify the new method, medications, or devices in treating ACC. Each medicine or drug approved by the FDA is presently used and tested in clinical trials. All stages and types of Adenoid Cystic Carcinoma are included in the clinical trial. The efficacy of clinical trials of ACC is determined by studying the treatment with amivantamab. It has shown effective result in treating metastatic and aggressive Adenoid Cystic Carcinoma.
The volunteers willingly participate in the clinical trial. The existing standard ones do not show much efficacy in managing disease conditions. Hence, patients consider clinical trials as the best treatment option for Adenoid Cystic Carcinoma Cancer. Participants sign informed consent forms before participation. They have the right to withdraw from the clinical trial phases at any point of time.
About Clinical Trials of Adenoid Cystic Carcinoma Cancer
Scientists always try for better strategies to treat and cure people with ACC (or any cancer in general). They research studies involving volunteers, known as clinical trials. Clinical Trials of Adenoid Cystic Carcinoma Cancer evaluate and verify different new approaches, medications or devices in treating ACC.
Clinical trials of Adenoid Cystic Carcinoma Cancer takes place for all stages and types of ACC. Most clinical trials focus on experimenting with new treatment options. They learn if a new treatment strategy is safe, effective and better than the existing ones. The tests also evaluate new combinations of treatments, drugs, and other latest approaches in radiation, surgery or other medicines 1. Currently, researchers are studying whether therapy with amivantamab would be effective in treating metastatic and aggressive Adenoid Cystic Carcinoma 2.
Researchers need volunteers to carry out clinical trials. These people are the first to use the new treatments and medications. After successful trial public can use this. As trials are new, it has many risk factors. Sometimes people may experience a few to a range of side effects, and there are also chances that the new study may not become successful. People interested in joining clinical trials should talk with their doctor and understand all possible pros and cons of the study. It helps people to make informed well-decided choices.
Joining a Clinical Trial
People come forward to participate in clinical trials for various reasons. Some patients consider clinical trials the best treatment option for Adenoid Cystic Carcinoma Cancer because the existing standard ones are not efficient in managing the disease condition. Hence people are often willing to try out clinical trials hoping that it will give them a better result. They join clinical trials with such hopes, even when they are uncertain about the impact of the trial.
Other patients and volunteers join clinical trials to help the trial progress and arrive at a beneficial result. They consider it as a way to contribute to ACC treatment and cure. They will be aware that they may not benefit from the trial, but they participate, hoping it will help future patients with Adenoid Cystic Carcinoma Cancer.
Clinical trials cost and insurance coverage can vary with the study and its location. In some cases, participants get reimbursement for participating in clinical trials whereas, in some others, they are not. So, people wanting to participate in clinical trials must talk with the team that carries out the research and your insurance company to learn more about costs and reimbursement.
In some clinical trials, people express the concern that they are not given any treatment but instead a placebo. Placebo refers to a sugar pill usually combined with standard cancer treatment procedures. So before any study involving the use of a placebo, patients or volunteers should be well informed.
Volunteers or patients wanting to join clinical trials must talk with their doctor/ healthcare team and research specialists to make well decided informed choices regarding participating in the trial. It is known as informed consent.
Doctors should describe how this trial differs from the standard treatment strategy of Adenoid Cystic Carcinoma Cancer. What are the benefits and risk factors associated with this study? Explain the eligibility criteria to participate in clinical trials.
Eligibility criteria for clinical trials ensure that the participants are safe and has no side effects. The participant and the research team will together review these criteria.
People who take part in clinical trials may withdraw their participation at any point in time due to any personal or medical conditions. It may be because the Adenoid Cystic Carcinoma Cancer treatment is not working or giving the desired results, including severe risks and side effects. Experts and scientists would closely monitor clinical trials to look for their good and bad impacts. Also, before participating in clinical trials, people should communicate with the concerned specialists and doctors to know who will manage their treatments and care during the trial and post the trial.
- 1.Feeney L, Jain Y, Beasley M, et al. Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic Carcinoma. Cancers. Published online August 27, 2021:4336. doi:10.3390/cancers13174336
- 2.Wong SJ, Karrison T, Hayes DN, et al. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. Annals of Oncology. Published online February 2016:318-323. doi:10.1093/annonc/mdv537